ProSciento is currently seeking participants who may be at an increased risk for developing Non-alcoholic Fatty Liver Disease (NAFLD) or Non-alcoholic steatohepatitis (NASH).
This is not a treatment study. There is no study drug or study device. This study will gather information about you and your health to determine your liver health status and potential eligibility for future studies relating to NAFLD/NASH.
NAFLD (non-alcoholic fatty liver disease) /Non-alcoholic steatohepatitis (NASH) is the most common liver disease in the United States. The term NAFLD (non-alcoholic fatty liver disease) describes a range of liver disease progression. When fatty liver disease advances to a more severe level of liver injury, it is called nonalcoholic steatohepatitis (NASH) basically scaring of the liver tissue. Some risk factors for these diseases include: being overweight, Type 2 Diabetes, and elevated Lab Results for: blood sugar, or liver enzymes, or HbA1c.
We would schedule you for a screening visit A and B (if applicable). In the first part of the visit A, you will sign the informed consent, review inclusion/exclusion of study, medical history, demographics, blood work and a Fibroscan. If you do not continue to visit B on same day, you will get a stipend of $25, if you do continue to Visit B, we will perform a physical exam, blood draw, smoking/alcohol history and MRI/MRE suitability criteria, you will get a stipend of $25, a total of $50 for Visit A and B.
Based on the outcome of visit A and B, Prosciento may ask you to have a liver biopsy for a current or upcoming study. If biopsy is completed, you will receive a stipend of $300.
If you are found to be at risk, you may be asked to participate in a sub-study that would require a liver biopsy and MRI.
Also, you may be asked by Prosciento to have an MRI for a current or upcoming study. If MRI is completed, you will receive a stipend of $300.
- Male or Female:
- Between the ages of 18 and 75
- Diagnosed with Type 2 Diabetes
- BMI higher than 25 (if not Type 2 Diabetic)
- HbA1c higher than 5.7%
- Elevated Liver Enzymes
Study Participants may receive:
- Compensation is available for this study. Call us today to learn more!
Sign Up Today
Each study has a set of criteria to determine a study participant’s eligibility. Please fill out our confidential online application. Our highly trained study participant recruiters will review your application and contact you if you may be a fit for a current or future study. Incomplete applications may not be seen—please ensure all applicable fields are filled out.
Get To Know Us
ProSciento’s clinical research facility is located 10 miles south of San Diego’s downtown area, 13 miles south of the San Diego International Airport, and 7 miles north of the US/Mexico border.
An on-site parking lot and parking garage are available and located within convenient access to public transportation. Additional transportation options may also be available at no-cost to study participants. Please ask your study participant recruiter for more information.
855 3rd Avenue,
Chula Vista, CA 91911
Monday – Friday
8:30 a.m. – 4:00 p.m.